Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients

Autologous hematopoietic stem cell transplantation (aHSCT) represents an effective treatment for systemic sclerosis (SSc), but it also can cause immunological adverse events (iAEs). Therefore, we aimed to determine the frequency of iAEs [engraftment syndrome (ES) and secondary autoimmune disorder (s...

Full description

Bibliographic Details
Main Authors: Patrick-Pascal Strunz, Matthias Froehlich, Michael Gernert, Eva Christina Schwaneck, Anna Fleischer, Ann-Christin Pecher, Hans-Peter Tony, Joerg Christoph Henes, Marc Schmalzing
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.723349/full